Sprachauswahl: PharmaLab Kongress - Deutschsprachige Version der WebsiteDE | PharmaLab Congress - Switch to the English version of the websiteEN

Endotoxin and Pyrogen Testing

8 and 9 November 2016

Objectives

This Conference will inform you about current developments in Endotoxin and Pyrogen testing as well as the practical use of established test methods like LAL for Endotoxin testing.

You become informed about

  • International regulatory developments
  • Feasibility of new and innovative products and methods
  • Special issues like masking/LER
  • testing of critical substances
  • Application of alternative testing methods – MAT or RFC

Highlights

  • News on European Pharmacopoeia
  • Low Endotoxin Recovery
    • Regulatory Point of View
    • Industrial LAL Experiences
    • Demasking Strategies
  • Current Way on RFC
  • MAT Experinences

Speakers

Authorities:

  • Dr Patricia Hughes, FDA, USA
  • Dr Ingo Spreitzer, Paul-Ehrlich-Institut, German Agency for Vaccines and Biomedicines, Germany

Industry and Academic:

  • Prof Jack Levin, University of California School of Medicine, USA
  • Prof Dr Klaus Brandenburg, Forschungszentrum Borstel
  • Dr Dayue Chen, Lilly, USA
  • John Dubczak, Charles River Laboratories
  • Dr Elena Gustchina, Lonza, USA
  • Dr Tarik Khan, Hoffman La-Roche, Switzerland
  • Dr Ned Mozier, Pfizer, USA
  • Johannes Reich, Universität Regensburg, Germany
  • Dr Astrid Visser, Sanquin Plasma Products , The Netherlands
  • Dr Jennifer Farrington, Associates of Cape Cod, USA
  • Tabea Hilmayr, Vetter Pharma Fertigung, Germany
  • Shabnam Solati, MAT Research, The Netherlands